Top compounds associated with response to P2RX5


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.024 0.7
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.7
mRNA L-685458 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Crizotinib gCSI pan-cancer AAC 0.023 0.7
mRNA CIL56 CTRPv2 pan-cancer AAC 0.018 0.7
Download CSV